Does prophylactic administration of somatostatin decrease the rates of complications after pancreatic resection?: A clinical and electron microscopy study

Pancreas

Volumn 42, Issue 1, 2013, Pages 37-41

  Katsourakis, Anastasios ^a   Zezos, Petros ^b   Noussios, George ^a   Kouklakis, George ^b   Chatzitheoklitos, Efthymios ^a   Simopoulos, Konstantinos ^c   Pitiakoudis, Michael ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

Author keywords

complications; pancreatic resection; somatostatin

Indexed keywords

AMYLASE; SOMASTIN SB; SOMATOSTATIN 14; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ABDOMINAL COLLECTION; ABDOMINAL DISEASE; ACINAR CELL; ADULT; AGED; ARTICLE; CELL ULTRASTRUCTURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DELAYED GASTRIC EMPTYING; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NAUSEA AND VOMITING; PANCREAS BIOPSY; PANCREAS FISTULA; PANCREAS FUNCTION; PANCREAS RESECTION; PANCREAS SECRETION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RASH; RESPIRATORY TRACT INFECTION; SEPSIS; SHOCK; STOMACH EMPTYING; URINARY TRACT INFECTION; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DRUG ADMINISTRATION SCHEDULE; FEMALE; GREECE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PANCREAS; PANCREATECTOMY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SOMATOSTATIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872070969     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182557c24     Document Type: Article

References (19)

1. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, outcomes. Ann Surg. 1997;226:248-260.
2. Strasberg SM, Drebin JA, Soper NJ. Evolution and current status of the Whipple procedure: an update for gastroenterologists. Gastroenterology. 1997;113:983-994.
3. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221:59-66.
4. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995;130:295-300.
5. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68-73.
6. Yeo CJ. Management of complications following pancreaticoduodenectomy. Surg Clin North Am. 1995;75:913-924.
7. Closset J, Journe S, Mbotty F, et al. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy. Hepatogastroenterology. 2008;55:1818-1823.
8. Schmidt CM, Choi J, Powell ES, et al. Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomes. HPB Surg. 2009;2009:404-520.
9. Bu?chler M, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg. 1992;163:125-131.
10. Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg. 1994;81:265-269.
11. Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery. 1995;117:26-31.
12. Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg. 1995;82:1270-1273.
13. Yeo CJ. Does prophylactic octreotide benefit patients undergoing elective pancreatic resection? J Gastrointest Surg. 1999;3:223-224.
14. Lowy AM, Lee JE, Pisters PWT, et al. Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg. 1997;226:632-641.
15. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Ann Surg. 2000;232:419-429.
16. Connor S, Alexakis N, Garden OJ, et al. Meta-analysis of the value of somatostatin and its analogues reducing complications associated pancreatic surgery. BJS. 2005;92:1059-1067.
17. Zeng Q Zhang Q Han S et al. Efficacy of somatostatin in prevention of postoperative complications after pancreaticoduodenectomy a Meta-analysis Of Randomized Controlled Trials. Pancreas. 2008;3618-25
18. Gurusamy KS, Koti RS, Fusai G, et al. Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev. 2010;17:CD008370.
19. Heintges T, Lu?then R, Niederau C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion. 1994;55(suppl 1):1-9.